Jenken Biosciences, Inc.
Records under this name other than patents Jenken Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Jenken Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,923,454 | Opioid and opioid-like compounds and uses thereof Formerly held Term ended Term ended Jan 27, 2025 · USPTO record | Term ended | Term ended Jan 27, 2025 | USPTO record |
| US 8,017,622 | Opioid and opioid-like compounds and uses thereof Formerly held Term ended Ended no later than May 16, 2023 · USPTO record | Term ended | Ended no later than May 16, 2023 | USPTO record |
| US 9,776,971 | Opioid and opioid-like compounds and uses thereof Formerly held Term ended Ended no later than May 16, 2023 · USPTO record | Term ended | Ended no later than May 16, 2023 | USPTO record |
| US 8,404,706 | Opioid and opioid-like compounds and uses thereof Formerly held Lapsed on the fee record Ended Mar 26, 2021 · USPTO record | Lapsed on the fee record | Ended Mar 26, 2021 | USPTO record |
| US 7,501,433 | Opioid and opioid-like compounds and uses thereof Formerly held Lapsed on the fee record Ended Mar 10, 2021 · USPTO record | Lapsed on the fee record | Ended Mar 10, 2021 | USPTO record |
| US 8,138,165 | Chromones and chromone derivatives and uses thereof Formerly held Lapsed on the fee record Ended Mar 20, 2020 · USPTO record | Lapsed on the fee record | Ended Mar 20, 2020 | USPTO record |